Regina Inokon
Psychiatric/Mental Health · Newark, NJNPI 1982210969
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 280 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Viiv Healthcare Company at 37.8% of the total. Among psychiatric/mental health clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 280 payments — averaging $23.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$2K
- Gilead$2K
- Johnson & Johnson$534
- AbbVie$527
- Otsuka America Pharmaceutical, Inc.$314
- Merck$269
- plus $804 from 12 others
What the payments were for
- Food & beverage$6,494100%
- Education$300%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 118 | $2,468 |
| Gilead | 98 | $1,607 |
| Johnson & Johnson(2 entities) | 13 | $534 |
| AbbVie | 5 | $527 |
| Otsuka America Pharmaceutical, Inc. | 4 | $314 |
| Merck | 17 | $269 |
| EMD Serono, Inc. | 11 | $181 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| E.r. Squibb & Sons, L.L.C. | 1 | $122 |
| Axsome Therapeutics, Inc. | 1 | $109 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $103 |
| Alkermes, Inc. | 3 | $47 |
| Theratechnologies Inc. | 2 | $45 |
| GSK | 1 | $17 |
| Neurocrine Biosciences, Inc. | 1 | $16 |
| Amgen | 1 | $15 |
| Pfizer | 1 | $14 |
| Phadia US Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$498
- INVEGA SUSTENNA$355
- ABILIFY ASIMTUFII$250
- ABILIFY MAINTENA$250
- APRETUDE$250
- CABENUVA$232
- Biktarvy$125
- Descovy$125
- Yeztugo$125
- Austedo XR$122
- COBENFY$122
- DOVATO$117
- Auvelity$109
- CAPLYTA$103
How this compares
$6,523 in reported general payments places this provider in the 95th percentile of 1,212 psychiatric/mental health providers in New Jersey.
Other psychiatric/mental health in Newark
- Ubong UdofiaMarlton$407K
- Anthony DimuraRed Bank$130K
- Amy PinsenNewton$111K
- Aaron SpectorMarlton$100K
- Fiorella ParadisiSparta$84K
- Diane BurtBridgeton$81K
- Alta ManessHackensack$75K
- Laura LeahySewell$41K
- Linda WinfulMontclair$40K
- Marisa SavicOradel$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.